Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Birrer

Showing results (31-40 of 222) with videos related to

Pageof 23
Sort By:
Gynecologic Oncology|November 6, 2009
NIH and NCI support for development of novel therapeutics in gynecologic cancer: a user's guideLucas Minig, Edward L Trimble, Michael J Birrer, et al.
Oncogene|May 14, 2003
Identification of cJun-responsive genes in Rat-1a cells using multiple techniques: increased expression of stathmin is necessary for cJun-mediated anchorage-independent growthIchiro Kinoshita, Virna Leaner, Motoo Katabami, et al.
BMC Cancer|February 3, 2021
Inhibition of Kpnβ1 mediated nuclear import enhances cisplatin chemosensitivity in cervical cancerRu-Pin Alicia Chi, Pauline van der Watt, Wei Wei, et al.
Advances in Cancer Research|December 13, 2006
Biomarker discovery in epithelial ovarian cancer by genomic approachesSamuel C Mok, Kevin M Elias, Kwong-Kwok Wong, et al.
Biological Chemistry|March 23, 2011
Inhibition of AP-1 suppresses cervical cancer cell proliferation and is associated with p21 expressionMichelle F Maritz, Pauline J van der Watt, Nina Holderness, et al.
Oncology|November 24, 2004
Cyclin E amplification and overexpression in clear cell adenocarcinoma of the ovaryHiroshi Tsuda, Christina A Bandera, Michael J Birrer, et al.
The American Journal of Pathology|December 17, 2008
Inhibition of AP-1 transcriptional activity blocks the migration, invasion, and experimental metastasis of murine osteosarcomaVirna D Leaner, Jeffrey F Chick, Howard Donninger, et al.
Frontiers in Oncology|March 14, 2022
The Changing Landscape of Systemic Treatment for Cervical Cancer: Rationale for Inhibition of the TGF-β and PD-L1 PathwaysMichael J Birrer, Keiichi Fujiwara, Ana Oaknin, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 13, 2014
Deep, noninvasive imaging and surgical guidance of submillimeter tumors using targeted M13-stabilized single-walled carbon nanotubesDebadyuti Ghosh, Alexander F Bagley, Young Jeong Na, et al.
The Journal of Biological Chemistry|May 10, 2003
Cross-talk between JNK/SAPK and ERK/MAPK pathways: sustained activation of JNK blocks ERK activation by mitogenic factorsYing H Shen, Jakub Godlewski, Jun Zhu, et al.
Pageof 23

Showing results (31-40 of 222) with videos related to

Sort By:
Pageof 23
Gynecologic Oncology|November 6, 2009
NIH and NCI support for development of novel therapeutics in gynecologic cancer: a user's guideLucas Minig, Edward L Trimble, Michael J Birrer, et al.
Oncogene|May 14, 2003
Identification of cJun-responsive genes in Rat-1a cells using multiple techniques: increased expression of stathmin is necessary for cJun-mediated anchorage-independent growthIchiro Kinoshita, Virna Leaner, Motoo Katabami, et al.
BMC Cancer|February 3, 2021
Inhibition of Kpnβ1 mediated nuclear import enhances cisplatin chemosensitivity in cervical cancerRu-Pin Alicia Chi, Pauline van der Watt, Wei Wei, et al.
Advances in Cancer Research|December 13, 2006
Biomarker discovery in epithelial ovarian cancer by genomic approachesSamuel C Mok, Kevin M Elias, Kwong-Kwok Wong, et al.
Biological Chemistry|March 23, 2011
Inhibition of AP-1 suppresses cervical cancer cell proliferation and is associated with p21 expressionMichelle F Maritz, Pauline J van der Watt, Nina Holderness, et al.
Oncology|November 24, 2004
Cyclin E amplification and overexpression in clear cell adenocarcinoma of the ovaryHiroshi Tsuda, Christina A Bandera, Michael J Birrer, et al.
The American Journal of Pathology|December 17, 2008
Inhibition of AP-1 transcriptional activity blocks the migration, invasion, and experimental metastasis of murine osteosarcomaVirna D Leaner, Jeffrey F Chick, Howard Donninger, et al.
Frontiers in Oncology|March 14, 2022
The Changing Landscape of Systemic Treatment for Cervical Cancer: Rationale for Inhibition of the TGF-β and PD-L1 PathwaysMichael J Birrer, Keiichi Fujiwara, Ana Oaknin, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 13, 2014
Deep, noninvasive imaging and surgical guidance of submillimeter tumors using targeted M13-stabilized single-walled carbon nanotubesDebadyuti Ghosh, Alexander F Bagley, Young Jeong Na, et al.
The Journal of Biological Chemistry|May 10, 2003
Cross-talk between JNK/SAPK and ERK/MAPK pathways: sustained activation of JNK blocks ERK activation by mitogenic factorsYing H Shen, Jakub Godlewski, Jun Zhu, et al.
Pageof 23